Michael S. Broder, MD

home / authors / michael-s-broder-md

Articles

July 12th 2011

Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast Cancer

Burton F. Vanderlaan, MD Michael S. Broder, MD Eunice Y. Chang, PhD Ruth Oratz, MD, FACP Tanya G. K. Bentley, PhD

A decision-analytic model was used to estimate cost-effectiveness of adopting a 21-gene assay in treatment decisions for women with early-stage N (1-3)/ER HER2-negative breast cancer.

March 9th 2010

Ratio of Controller to Total Asthma Medications: Determinants of the Measure

Michael S. Broder, MD Benjamin Gutierrez, PhD Eunice Chang, PhD David Meddis, PhD Michael Schatz, MD

The ratio of controller to total asthma medications can be calculated using 1 or 2 quarters of data; high versus low ratios differentiate patient characteristics.